Rossmore Private Capital Amgen Inc Transaction History

Rossmore Private Capital

$804 Million
Q3 2024

A detailed history of Rossmore Private Capital transactions in Amgen Inc stock. As of the latest transaction made, Rossmore Private Capital holds 4,008 shares of AMGN stock, worth $1.04 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

4,008

Previous 4,008 -0.0%

Holding current value

$1.04 Million

Previous $1.25 Million 3.12%

% of portfolio

0.16%

Previous 0.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $29,405 - $33,172	-115 Reduced 2.79%	4,008 $1.15 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $10,932 - $13,572	50 Added 1.23%	4,123 $1.11 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $9,642 - $11,401	45 Added 1.12%	4,073 $904,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $1,128 - $1,376	-5 Reduced 0.12%	4,028 $973,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $38,018 - $48,307	166 Added 4.29%	4,033 $1.06 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $54,543 - $61,515	243 Added 6.71%	3,867 $872,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $142,809 - $158,922	619 Added 20.6%	3,624 $882,000
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $11,182 - $12,371	-51 Reduced 1.67%	3,005 $727,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $27,843 - $31,864	-140 Reduced 4.38%	3,056 $688,000
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $21,227 - $24,870	100 Added 3.23%	3,196 $680,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $23,124 - $25,654	-99 Reduced 3.1%	3,096 $755,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $217,027 - $252,910	-978 Reduced 23.44%	3,195 $795,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $3,894 - $4,638	18 Added 0.43%	4,173 $959,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $70,395 - $78,285	300 Added 7.78%	4,155 $1.06 Million
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $134,906 - $165,548	682 Added 21.49%	3,855 $909,000
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $9,476 - $12,568	-52 Reduced 1.61%	3,173 $643,000
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $5,223 - $6,258	30 Added 0.94%	3,225 $624,000
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $27,130 - $30,582	150 Added 4.93%	3,195 $607,000
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $35,680 - $41,650	200 Added 7.03%	3,045 $593,000
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $105,615 - $119,067	570 Added 25.05%	2,845 $590,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $186,373 - $217,800	1,100 Added 93.62%	2,275 $388,000
Q4 2017 Mar 15, 2018	BUY	$168.79 - $188.59 $198,328 - $221,593	1,175	1,175 $204 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.

Account

Rossmore Private Capital Amgen Inc Transaction History